Keeping Up With Hematologic Advances in Clayton
We headed to Clayton, Missouri for a State of the Science Summit on Hematologic Malignancies, which focused on novel agents in chronic lymphocytic leukemia, advances in acute myeloid leukemia, progress in myeloproliferative neoplasms, and more.
We headed to Clayton, Missouri for a State of the Science Summit on Hematologic Malignancies. The meeting covered novel agents and combinations in chronic lymphocytic leukemia, advances in acute myeloid leukemia, management of newly diagnosed and relapsed/refractory multiple myeloma, progress in myeloproliferative neoplasms, patient selection for Hodgkin lymphoma therapy, and more.
